BNET Industries

Inex Pharmaceuticals Corp.

IEX is in the Pharma Industry

Market Cap:$2.4B
Last Fiscal Year Sales:$15.2M
  • Public
  • CA
Dow Jones Description

Tekmira Pharmaceuticals Corporation is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer and other diseases. Tekmira, originally Inex Pharmaceuticals Corporation, was founded in 1992 based on the drug delivery technologies developed by Dr. Pieter Cullis, Inex's co-founder and former Chief Scientific Officer, and his scientific team at the University of British Columbia.

President, Chief Executive Officer, Director
Mark J Murray
Number of Employees 35
Contact Information

Ste 100 8900 Glenlyon Pkwy

Burnaby, British Columbia

www.inexpharm.c...

(604) 419-3200

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

News & Analysis

inex pharmaceuticals corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Mark J Murray President, Chief Executive Officer, Director
Ian C. Mortimer Executive Vice President, Finance and Chief Financial Officer
Ian MacLachlan Executive Vice President and Chief Scientific Officer
Peter Lutwyche Vice President, Pharmaceutical Development
Tammy Mullarky Vice President, Strategic Planning and Business Development
Arthur Bruskin Director
Donald Jewell Director
Dr James J Miller Director
M Ingle Director
Michael D. Casey Director
Michael J. Abrams Director
R Ian Lennox Director

Board of Directors

Name (plus bio) Position
Darrell Elliott Chairman
K. Michael Forrest Chairman
Blake Ingle Board of Directors
David J. Main Board of Directors
Don McCarren Board of Directors
Gary E. Frashier Board of Directors
James W. Hudson Board of Directors
Pieter R. Cullis Board of Directors

Organization Position Status
Inex Pharmaceuticals Corporation President, Chief Executive Officer, Director Current

Organization Position Status
Inex Pharmaceuticals Corporation Executive Vice President, Finance and Chief Financial Officer Current
Inex Corp. Current
Inex Pharmaceuticals Corporation Officer Former
University of British Columbia B.Sc. In Microbiology Former

Organization Position Status
Protiva Biotherapeutics Chief Scientific Officer Current
Inex Pharmaceuticals Corporation Executive Vice President and Chief Scientific Officer Current
Oligonucleotide Therapeutics Society, Inc Board of Directors Current
New York Academy of Sciences Board of Directors Current
Oligonucleotide Therapeutics Society, Inc Member Current
New York Academy of Sciences Member Current
Inex Pharmaceuticals Corporation Head of Gene Transfer Technology Former
National Cancer Institute Former
University of Alberta Ph.D. In Biochemistry Former
University of Alberta B.Sc. Former

Organization Position Status
Inex Pharmaceuticals Corporation Vice President, Pharmaceutical Development Current
Inex Pharmaceuticals Corporation Research Scientist Former
University of British Columbia Ph.D. In Chemistry Former

Tammy Mullarky brings considerable licensing and business development experience to TGI. Previously a Vice President of Business Development at Epigenomics, a publicly traded molecular diagnostics company based in Berlin with offices in Seattle, Tammy built the business development team and negotiated key alliances including a $100M strategic alliance. Her prior experience also includes 5 years in Mergers & Acquisitions at F. Hoffman la Roche in Basel, Switzerland and 4 years as a founder and VP of Anormed, a cancer and HIV therapeutics company.

Organization Position Status
Targeted Growth, Inc Senior Vice President Current
Inex Pharmaceuticals Corporation Vice President, Strategic Planning and Business Development Current
AnorMED, Inc. Founder Former
AnorMED, Inc. Senior Executive Former
Whitman College Bachelor's Degree In Biochemistry Former

Organization Position Status
Aeron Wine Cellars Senior Vice President and Managing Director, Private Current
Chromos Molecular Systems Inc. Chair of Board Current
Inex Pharmaceuticals Corporation Chairman Current
Protiva Biotherapeutics Chairman Current
IsoTis S.A. Chairman Current
Aderis Pharmaceuticals, Inc. Board of Directors Current
IsoTis S.A. Board of Directors Current
Aeron Wine Cellars Board of Directors Current
Cognetix, Inc. Chairman Former
Chromos Molecular Systems Inc. Board of Directors Former
Inex Pharmaceuticals Corporation Board of Directors Former
University of South Africa Ba (Hons) Economics Degree Former

Organization Position Status
AVI BioPharma, Inc. Outside Director Current
Inex Pharmaceuticals Corporation Chairman Current
AVI BioPharma, Inc. Board of Directors Current
AVI BioPharma, Inc. Interim CEO Former
United States Air Force Former
Georgetown University B.S. In Business Administration Former

Organization Position Status
Rishi Pharmaceuticals, Inc. Current
Inex Pharmaceuticals Corporation Director Current
Developmental Biology M.S. Former
University of Connecticut M.S. Former
Developmental Biology B.A. Former
University of Connecticut B.A. Former

Organization Position Status
Inglewood Ventures Current
Bridgetech Holdings International, Inc. Board of Directors Current
Cengent Therapeutics, Inc. Board of Directors Current
Dendreon Corporation Board of Directors Current
Inex Pharmaceuticals Corporation Board of Directors Current
Vical Incorporated Board of Directors Current
The Burnham Institute Chairman Former

Organization Position Status
Aquinox Pharmaceuticals Inc. Chairman, President & CEO Current
Inex Pharmaceuticals Corporation Board of Directors Current
Inex Pharmaceuticals Corporation CEO Former
Inex Pharmaceuticals Corporation President Former

Organization Position Status
Inex Pharmaceuticals Corporation Board of Directors Current

Organization Position Status
Inex Pharmaceuticals Corporation Director Current
Rogers Sugar Ltd. Board of Directors Current
Protiva Biotherapeutics Board of Directors Current
Lantic Sugar Limited Board of Directors Current

Organization Position Status
Neuro Discovery Limited CEO Current
Penderfund Capital Management Ltd Chief Technical Advisor and Director Current
Trian Equities Ltd. Senior Vice President Current
Medical Ventures Corp. James Miller, MD (Director) Current
Allon Therapeutics Inc Chairman and Director Current
Inviro Medical Devices, Inc. Current
Stressgen Biotechnologies Corporation Current
Neuro Discovery Limited Chairman Current
Chromos Molecular Systems Inc. Director Current
Neuromed Pharmaceuticals, Inc. Director Current
Medical Ventures Corp. Board of Directors Current
Protox Therapeutics Inc. Board of Directors Current
Inex Pharmaceuticals Corporation Director Current
Penderfund Capital Management Ltd Board of Directors Current
Gateway Casinos Income Fund Chairman, President and CEO of Neuro Discovery Inc. Former
Inex Pharmaceuticals Corporation CEO Former
QLT, Inc. Chairman, President and Chief Executive Officer Former
Neuromed Pharmaceuticals, Inc. Chairman & Chief Executive Officer, Ndi Capital Former
Neuro Discovery Limited President Former
Inex Pharmaceuticals Corporation President Former
Neuro Discovery Limited Founder Former
Inex Pharmaceuticals Corporation Founder Former
Trian Equities Ltd. Senior Portfolio Manager Former
University of British Columbia Faculty Former
Inex Corp. Chairman Former
The University of Western Ontario Ph.D. In Physiology Former
The University of Western Ontario M.A. In Psychology Former

Organization Position Status
Management Associates, LLC President Current
Management Associates, LLC Principal Current
Alseres Pharmaceuticals, Inc. Committee Chair for Nominating and Governance Committee Current
Achillion Pharmaceuticals, Inc Board of Directors Current
Tekmira Pharmaceuticals Corporation Board of Directors Current
Inex Pharmaceuticals Corporation Board of Directors Current
Aderis Pharmaceuticals, Inc. Board of Directors Current
Apex Bioventures Acquisition Corporation Board of Directors Current
Alseres Pharmaceuticals, Inc. Board of Directors Current
Genex Inc. CEO Former
OSI Pharmaceuticals, Inc. Chief Executive Officer Former
Genex Inc. President Former
Apex Bioventures Acquisition Corporation CFO, Secretary & Executive Vice President Former
Millipore Corporation Executive Vice President Former
OSI Pharmaceuticals, Inc. Chairman Former
Texas Tech University B.S In Chemical Engineering Former

Mr. Hudson is the General Manager of Richmond Country Club, a private country club located in Richmond, B.C. Until November 2004, Mr. Hudson was the Chief Administrative Officer at the Vancouver Police Department. Prior to this Mr. Hudson was Senior Vice President, Finance and Chief Financial Officer at Kinetek Pharmaceuticals Inc. from 2000 to 2003, where he assumed a lead role in devising and implementing the company's business development and operating strategies. From 1998 to 1999, Mr. Frashier was Vice President and Chief Financial Officer at BC Belting, and from 1989 to 1997 he served as Vice President, Finance and Chief Financial Officer at BC Sugar. During that time, Mr. Hudson played key roles in BC Sugar's 1992 acquisition of Lantic Sugar, the raising of more than $90 million in common share equity and a variety of other corporate acquisitions and divestitures.

Organization Position Status
Richmond Country Club, Inc General Manager Current
Inex Pharmaceuticals Corporation Board of Directors Current

Organization Position Status
Quorex Pharmaceuticals, Inc. Strategic Advisor Current
Inglewood Ventures Current
Inex Pharmaceuticals Corporation Director Current
Cengent Therapeutics, Inc. Director Current
The Burnham Institute Chairman Former

Organization Position Status
DURECT Corporation Director, Chairman of the Nominating and Governance Committee Current
Allos Therapeutics, Inc. Pharmaceutical Industry Consultant Current
DURECT Corporation Director Current
Cholestech Corporation Director Current
Lead Discovery Board of Directors Current
AVI BioPharma, Inc. Director Current
Bone Care International, Inc. Director Current
Celgene Corporation Board of Directors Current
Inex Pharmaceuticals Corporation Director Current
Orthologic Corporation Director Current
Allos Therapeutics, Inc. Director Current
Multiple Myeloma Committee Member Current
Pharmion Corporation Committee Member Current
Rare Diseases Clinical Research Network Committee Member Current
Genetic Therapy, Inc. President Former
Genetic Therapy, Inc. Chief Operating Officer Former
Ortho Pharmaceutical Corporation Vice President, Sales and Marketing Former
Johnson & Johnson Vice President of Sales and Marketing Former

Organization Position Status
BC Business Magazine Current
Inex Pharmaceuticals Corporation Director Current
Protiva Biotherapeutics Board of Directors Current
Migenix, Inc. Director Current
AnorMED, Inc. Board of Directors Current
AnorMED, Inc. CEO Former
AnorMED, Inc. President Former
AnorMED, Inc. Co-Founder Former
University of British Columbia Adjunct Professor Former
Johnson Matthey, Inc. Former
Massachusetts Institute Ph.D. In Chemistry Former
Massachusetts Institute of Technology Ph.D. in chemistry Former
Bowdoin College BA In Chemistry Former

Organization Position Status
Inex Pharmaceuticals Corporation Board of Directors Current

Organization Position Status
Ricerca Biosciences LLC Chairman & CEO Current
Stressgen Biotechnologies Corporation Current
Protiva Biotherapeutics Board of Directors Current
Ambit Biosciences Corporation Board of Directors Current
Merge Healthcare Board of Directors Current
Inex Pharmaceuticals Corporation Director Current
Merge Technologies Incorporated Board of Directors Current
Spectral Diagnostics Inc. Director Current
Monsanto Company Chief Executive Officer Former
Monsanto Company President Former
Hemosol Corp. Director Former
The University of Western Ontario Masters of Business and HSBc Former
The University of Western Ontario B.S. Degree In Physiology Former
The University of Western Ontario Degree Former
Columbia Business School Former
advertisement
IEX $30.57 -0.05 (-0.16% )
Volume 292,733
Shares Outstanding 80.8M
Market Cap 2.4B
Year High 31.55
Year Low 16.67
Earnings Per Share 1.30
P/E Ratio 23.5154
Dividend 0.48
Yield 1.57
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Presented by American Express